Prions ex vivo: What cell culture models tell us about infectious proteins

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Krauss, Sybille ^a   Vorberg, Ina ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; POLYGLUTAMINE; PRION PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL CULTURE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; CYTOSOL; DAUGHTER CELL; DEGENERATIVE DISEASE; EX VIVO STUDY; EXON; EXOSOME; FIBROBLAST CULTURE; HOST CELL; HUNTINGTON CHOREA; LIFE CYCLE; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMERIZATION; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; VERTICAL TRANSMISSION;

EID: 84887432908     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/704546     Document Type: Review

References (162)

1. Aguzzi A., Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. Journal of Neurochemistry 2006 97 6 1726 1739 2-s2.0-33745047301 10.1111/j.1471-4159.2006.03909.x (Pubitemid 43873663)
2. Dickinson A. G., Meikle V. M., A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genetical Research 1969 13 2 213 225 2-s2.0-0014500760
3. Hecker R., Taraboulos A., Scott M., Pan K.-M., Yang S.-L., Torchia M., Jendroska K., DeArmond S. J., Prusiner S. B., Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes and Development 1992 6 7 1213 1228 2-s2.0-0026729945
4. Taraboulos A., Jendroska K., Serban D., Yang S.-L., DeArmond S. J., Prusiner S. B., Regional mapping of prion proteins in brain. Proceedings of the National Academy of Sciences of the United States of America 1992 89 16 7620 7624 2-s2.0-0026644090
5. Prusiner S. B., Novel proteinaceous infectious particles cause scrapie. Science 1982 216 4542 136 144 2-s2.0-0020321767 (Pubitemid 12089840)
6. Legname G., Baskakov I. V., Nguyen H.-O. B., Riesner D., Cohen F. E., DeArmond S. J., Prusiner S. B., Synthetic mammalian prions. Science 2004 305 5684 673 676 2-s2.0-3442889359 10.1126/science.1100195 (Pubitemid 39006757)
7. Deleault N. R., Harris B. T., Rees J. R., Supattapone S., Formation of native prions from minimal components in vitro. Proceedings of the National Academy of Sciences of the United States of America 2007 104 23 9741 9746 2-s2.0-34547491652 10.1073/pnas.0702662104 (Pubitemid 47175337)
8. Wang F., Wang X., Yuan C.-G., Ma J., Generating a prion with bacterially expressed recombinant prion protein. Science 2010 327 5969 1132 1135 2-s2.0-77649213673 10.1126/science.1183748
9. Bessen R. A., Marsh R. F., Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. Journal of Virology 1994 68 12 7859 7868 2-s2.0-0028043661 (Pubitemid 24362673)
10. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B., Eight prion strains have PrP(Sc) molecules with different conformations. Nature Medicine 1998 4 10 1157 1165 2-s2.0-0031720905 10.1038/2654 (Pubitemid 28468829)
11. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B., Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996 274 5295 2079 2082 2-s2.0-12644272790 10.1126/science.274.5295.2079 (Pubitemid 27020700)
12. Linden R., Martins V. R., Prado M. A. M., Cammarota M., Izquierdo I., Brentani R. R., Physiology of the prion protein. Physiological Reviews 2008 88 2 673 728 2-s2.0-42049099020 10.1152/physrev.00007.2007 (Pubitemid 351520090)
13. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B., Conversion of α -helices into β -sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences of the United States of America 1993 90 23 10962 10966 2-s2.0-0027332116 10.1073/pnas.90.23.10962 (Pubitemid 23354348)
14. Tzaban S., Friedlander G., Schonberger O., Horonchik L., Yedidia Y., Shaked G., Gabizon R., Taraboulos A., Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002 41 42 12868 12875 2-s2.0-0037159185 10.1021/bi025958g (Pubitemid 35192516)
15. Knowles T. P. J., Waudby C. A., Devlin G. L., Cohen S. I. A., Aguzzi A., Vendruscolo M., Terentjev E. M., Welland M. E., Dobson C. M., An analytical solution to the kinetics of breakable filament assembly. Science 2009 326 5959 1533 1537 2-s2.0-72149118250 10.1126/science.1178250
16. Silveira J. R., Raymond G. J., Hughson A. G., Race R. E., Sim V. L., Hayes S. F., Caughey B., The most infectious prion protein particles. Nature 2005 437 7056 257 261 2-s2.0-24644448839 10.1038/nature03989 (Pubitemid 41294488)
17. Saborio G. P., Permanne B., Soto C., Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001 411 6839 810 813 2-s2.0-0035859102 10.1038/35081095 (Pubitemid 32588105)
18. Wickner R. B., Masison D. C., Evidence for two prions in yeast: [URE3] and [PSI]. Current Topics in Microbiology and Immunology 1996 207 147 160 2-s2.0-0029655338
19. Tanaka M., Collins S. R., Toyama B. H., Weissman J. S., The physical basis of how prion conformations determine strain phenotypes. Nature 2006 442 7102 585 589 2-s2.0-33746698975 10.1038/nature04922 (Pubitemid 44167919)
20. Wegrzyn R. D., Bapat K., Newnam G. P., Zink A. D., Chernoff Y. O., Mechanism of prion loss after Hsp104 inactivation in yeast. Molecular and Cellular Biology 2001 21 14 4656 4669 2-s2.0-0034960225 10.1128/MCB.21.14.4656- 4669.2001 (Pubitemid 32588248)
21. Derdowski A., Sindi S. S., Klaips C. L., DiSalvo S., Serio T. R., A size threshold limits prion transmission and establishes phenotypic diversity. Science 2010 330 6004 680 683 2-s2.0-78049408567 10.1126/science.1197785
22. Béranger F., Mangé A., Solassol J., Lehmann S., Cell culture models of transmissible spongiform encephalopathies. Biochemical and Biophysical Research Communications 2001 289 2 311 316 2-s2.0-0035976776 10.1006/bbrc.2001.5941 (Pubitemid 33141054)
23. Piccardo P., Cervenakova L., Vasilyeva I., Yakovleva O., Bacik I., Cervenak J., McKenzie C., Kurillova L., Gregori L., Pomeroy K., Asher D. M., Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies. Emerging Infectious Diseases 2011 17 12 2262 2269 2-s2.0-82755174046 http://dx.doi.org/10.3201/eid1712.110607
24. Rubenstein R., Hui D., Race R., Ju W., Scalici C., Papini M., Kascsak R., Carp R., Replication of scrapie strains in vitro and their influence on neuronal functions. Annals of the New York Academy of Sciences 1994 724 331 337 2-s2.0-0028235046 10.1111/j.1749-6632.1994.tb38924.x (Pubitemid 24223738)
25. Nishida N., Harris D. A., Vilette D., Laude H., Frobert Y., Grassi J., Casanova D., Milhavet O., Lehmann S., Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. Journal of Virology 2000 74 1 320 325 2-s2.0-0033988236 (Pubitemid 30002912)
26. Bosque P. J., Prusiner S. B., Cultured cell sublines highly susceptible to prion infection. Journal of Virology 2000 74 9 4377 4386 2-s2.0-0033999635 10.1128/JVI.74.9.4377-4386.2000 (Pubitemid 30214445)
27. Vorberg I., Raines A., Story B., Priola S. A., Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. Journal of Infectious Diseases 2004 189 3 431 439 2-s2.0-1142285202 10.1086/381166 (Pubitemid 38210579)
28. Lehmann S., Prion propagation in cell culture. Methods in Molecular Biology 2005 299 227 234 2-s2.0-22844447952
29. Baron G. S., Magalhães A. C., Prado M. A. M., Caughey B., Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. Journal of Virology 2006 80 5 2106 2117 2-s2.0-33144469836 10.1128/JVI.80.5.2106-2117.2006 (Pubitemid 43271518)
30. Grassmann A., Wolf H., Hofmann J., Graham J., Vorberg I., Cellular aspects of prion replication in vitro. Viruses 2013 5 1 374 405
31. Greil C. S., Vorberg I. M., Ward A. E., Meade-White K. D., Harris D. A., Priola S. A., Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. Virology 2008 379 2 284 293 2-s2.0-50349085804 10.1016/j.virol.2008.07.006
32. Paquet S., Daude N., Courageot M.-P., Chapuis J., Laude H., Vilette D., PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells. Journal of Virology 2007 81 19 10786 10791 2-s2.0-34648822337 10.1128/JVI.01137-07 (Pubitemid 47463351)
33. Caughey B., Raymond G. J., The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase- sensitive. The Journal of Biological Chemistry 1991 266 27 18217 18223 2-s2.0-0025991466 (Pubitemid 21908068)
34. Vorberg I., Raines A., Priola S. A., Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. The Journal of Biological Chemistry 2004 279 28 29218 29225 2-s2.0-3142726518 10.1074/jbc.M402576200 (Pubitemid 38915796)
35. Goold R., Rabbanian S., Sutton L., Andre R., Arora P., Moonga J., Clarke A. R., Schiavo G., Jat P., Collinge J., Tabrizi S. J., Rapid cell-surface prion protein conversion revealed using a novel cell system. Nature Communications 2011 2 1, article 281 2-s2.0-79955050582 10.1038/ncomms1282
36. Taraboulos A., Serban D., Prusiner S. B., Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. Journal of Cell Biology 1990 110 6 2117 2132 2-s2.0-0025373111 10.1083/jcb.110.6.2117 (Pubitemid 20183169)
37. Veith N. M., Plattner H., Stuermer C. A. O., Schulz-Schaeffer W. J., Bürkle A., Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. European Journal of Cell Biology 2009 88 1 45 63 2-s2.0-57249089081 10.1016/j.ejcb.2008.08.001
38. Borchelt D. R., Taraboulos A., Prusiner S. B., Evidence for synthesis of scrapie prion proteins in the endocytic pathway. The Journal of Biological Chemistry 1992 267 23 16188 16199 2-s2.0-0026775909
39. McKinley M. P., Taraboulos A., Kenaga L., Serban D., Stieber A., DeArmond S. J., Prusiner S. B., Gonatas N., Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Laboratory Investigation 1991 65 6 622 630 2-s2.0-0026326210
40. Marijanovic Z., Caputo A., Campana V., Zurzolo C., Identification of an intracellular site of prion conversion. PLoS Pathogens 2009 5 5 2-s2.0-67249099366 10.1371/journal.ppat.1000426 e1000426
41. Naslavsky N., Stein R., Yanai A., Friedlander G., Taraboulos A., Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. The Journal of Biological Chemistry 1997 272 10 6324 6331 2-s2.0-0030894380 10.1074/jbc.272.10.6324 (Pubitemid 27118107)
42. Borchelt D. R., Scott M., Taraboulos A., Stahl N., Prusiner S. B., Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. Journal of Cell Biology 1990 110 3 743 752 2-s2.0-0025304678
43. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S. J., Smart E. J., Anderson R. G. W., Taraboulos A., Prusiner S. B., Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proceedings of the National Academy of Sciences of the United States of America 1996 93 25 14945 14949 2-s2.0-0029962468 10.1073/pnas.93.25.14945 (Pubitemid 26419075)
44. Yamasaki T., Suzuki A., Shimizu T., Watarai M., Hasebe R., Horiuchi M., Characterization of intracellular localization of PrPSc in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP. Journal of General Virology 2012 93 3 668 680 2-s2.0-84857095082 10.1099/vir.0.037101-0
45. Peretz D., Williamson R. A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I. R., Legname G., Wormald M. R., Rudd P. M., Dwek R. A., Burton D. R., Prusiner S. B., Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001 412 6848 739 743 2-s2.0-0035899413 10.1038/35089090 (Pubitemid 32771997)
46. Aguib Y., Heiseke A., Gilch S., Riemer C., Baier M., Schätzl H. M., Ertmer A., Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 2009 5 3 361 369 2-s2.0-65249103439 10.4161/auto.5.3.7662
47. Ertmer A., Gilch S., Yun S.-W., Flechsig E., Klebl B., Stein-Gerlach M., Klein M. A., Schätzl H. M., The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells. The Journal of Biological Chemistry 2004 279 40 41918 41927 2-s2.0-4744361580 10.1074/jbc.M405652200 (Pubitemid 39313641)
48. Heiseke A., Aguib Y., Riemer C., Baier M., Schätzl H. M., Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. Journal of Neurochemistry 2009 109 1 25 34 2-s2.0-61849102412 10.1111/j.1471-4159.2009.05906.x
49. Schätzl H. M., Laszlo L., Holtzman D. M., Tatzelt J., Dearmond S. J., Weiner R. I., Mobley W. C., Prusiner S. B., A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. Journal of Virology 1997 71 11 8821 8831 2-s2.0-0037611374 (Pubitemid 27446466)
50. Ghaemmaghami S., Phuan P.-W., Perkins B., Ullman J., May B. C. H., Cohen F. E., Prusiner S. B., Cell division modulates prion accumulation in cultured cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 46 17971 17976 2-s2.0-36749073968 10.1073/pnas.0708372104 (Pubitemid 350210805)
51. Butler D. A., Scott M. R. D., Bockman J. M., Borchelt D. R., Taraboulos A., Hsiao K. K., Kingsbury D. T., Prusiner S. B., Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. Journal of Virology 1988 62 5 1558 1564 2-s2.0-0023928927
52. Race R. E., Caughey B., Graham K., Ernst D., Chesebro B., Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. Journal of Virology 1988 62 8 2845 2849 2-s2.0-0023785139
53. Watts J. C., Huo H., Bai Y., Ehsani S., Jeon A. H. W., Shi T., Daude N., Lau A., Young R., Xu L., Carlson G. A., Williams D., Westaway D., Schmitt-Ulms G., Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathogens 2009 5 10 e1000608 2-s2.0-73349140865
54. Jin T., Gu Y., Zanusso G., Sy M., Kumar A., Cohen M., Gambetti P., Singh N., The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. The Journal of Biological Chemistry 2000 275 49 38699 38704 2-s2.0-0034623960 10.1074/jbc.M005543200 (Pubitemid 32009203)
55. Xu F., Karnaukhova E., Vostal J. G., Human cellular prion protein interacts directly with clusterin protein. Biochimica et Biophysica Acta 2008 1782 11 615 620 2-s2.0-55049133701 10.1016/j.bbadis.2008.08.004
56. Heiseke A., Aguib Y., Schatzl H. M., Autophagy, prion infection and their mutual interactions. Current Issues in Molecular Biology 2010 12 2 87 97 2-s2.0-74749094631
57. Krammer C., Kryndushkin D., Suhre M. H., Kremmer E., Hofmann A., Pfeifer A., Scheibel T., Wickner R. B., Schätzl H. M., Vorberg I., The yeast Sup35NM domain propagates as a prion in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 2 462 467 2-s2.0-58849091748 10.1073/pnas.0811571106
58. Hofmann J. P., Denner P., Nussbaum-Krammer C., Cell-to-cell propagation of infectious cytosolic protein aggregates. Proceedings of the National Academy of Sciences of the United States of America 2013 110 15 5951 5956
59. Münch C., O'Brien J., Bertolotti A., Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proceedings of the National Academy of Sciences of the United States of America 2011 108 9 3548 3553 2-s2.0-79952743365 10.1073/pnas.1017275108
60. Ren P.-H., Lauckner J. E., Kachirskaia I., Heuser J. E., Melki R., Kopito R. R., Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biology 2009 11 2 219 225 2-s2.0-59649095699 10.1038/ncb1830
61. Rujano M. A., Bosveld F., Salomons F. A., Dijk F., van Waarde M. A. W. H., van der Want J. J. L., de Vos R. A. I., Brunt E. R., Sibon O. C. M., Kampinga H. H., Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes. PLoS Biology 2006 4 12, article e417 2-s2.0-34147187776 10.1371/journal.pbio.0040417 (Pubitemid 44917621)
62. Wang F., Zhang Z., Wang X., Li J., Zha L., Yuan C.-G., Weissmann C., Ma J., Genetic informational RNA is not required for recombinant prion infectivity. Journal of Virology 2012 86 3 1874 1876 2-s2.0-84857073753 10.1128/JVI.06216-11
63. Maas E., Geissen M., Groschup M. H., Rost R., Onodera T., Schätzl H., Vorberg I. M., Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. The Journal of Biological Chemistry 2007 282 26 18702 18710 2-s2.0-34547118602 10.1074/jbc.M701309200 (Pubitemid 47100146)
64. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., Raposo G., Cells release prions in association with exosomes. Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9683 9688 2-s2.0-3042788972 10.1073/pnas.0308413101 (Pubitemid 38869296)
65. Leblanc P., Alais S., Porto-Carreiro I., Lehmann S., Grassi J., Raposo G., Darlix J. L., Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO Journal 2006 25 12 2674 2685 2-s2.0-33745565356 10.1038/sj.emboj.7601162 (Pubitemid 43980376)
66. Alais S., Simoes S., Baas D., Lehmann S., Raposo G., Darlix J. L., Leblanc P., Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biology of the Cell 2008 100 10 603 615 2-s2.0-53349177064 10.1042/BC20080025
67. Vella L. J., Sharples R. A., Lawson V. A., Masters C. L., Cappai R., Hill A. F., Packaging of prions into exosomes is associated with a novel pathway of PrP processing. Journal of Pathology 2007 211 5 582 590 2-s2.0-33947709328 10.1002/path.2145 (Pubitemid 46502435)
68. Paquet S., Langevin C., Chapuis J., Jackson G. S., Laude H., Vilette D., Efficient dissemination of prions through preferential transmission to nearby cells. Journal of General Virology 2007 88 2 706 713 2-s2.0-33846818651 10.1099/vir.0.82336-0 (Pubitemid 46210911)
69. Kanu N., Imokawa Y., Drechsel D. N., Williamson R. A., Birkett C. R., Bostock C. J., Brockes J. P., Transfer of scrapie prion infectivity by cell contact in culture. Current Biology 2002 12 7 523 530 2-s2.0-0037006804 10.1016/S0960-9822(02)00722-4 (Pubitemid 34271365)
70. Gousset K., Schiff E., Langevin C., Marijanovic Z., Caputo A., Browman D. T., Chenouard N., de Chaumont F., Martino A., Enninga J., Olivo-Marin J.-C., Männel D., Zurzolo C., Prions hijack tunnelling nanotubes for intercellular spread. Nature Cell Biology 2009 11 3 328 336 2-s2.0-61849178720 10.1038/ncb1841
71. Capellari S., Parchi P., Russo C. M., Sanford J., Sy M.-S., Gambetti P., Petersen R. B., Effect of the E200K mutation on prion protein metabolism: comparative study of a cell model and human brain. American Journal of Pathology 2000 157 2 613 622 2-s2.0-0033873642 (Pubitemid 30626920)
72. Lehmann S., Harris D. A., Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proceedings of the National Academy of Sciences of the United States of America 1996 93 11 5610 5614 2-s2.0-0030006902 10.1073/pnas.93.11.5610 (Pubitemid 26159499)
73. Petersen R. B., Parchi P., Richardson S. L., Urig C. B., Gambetti P., Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. The Journal of Biological Chemistry 1996 271 21 12661 12668 2-s2.0-17544366508 10.1074/jbc.271.21.12661 (Pubitemid 26160942)
74. Capellari S., Zaidi S. I. A., Long A. C., Kwon E. E., Petersen R. B., The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. Journal of Alzheimer's Disease 2000 2 1 27 35 2-s2.0-0034045157 (Pubitemid 30353515)
75. Lorenz H., Windl O., Kretzschmar H. A., Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. The Journal of Biological Chemistry 2002 277 10 8508 8516 2-s2.0-0037041014 10.1074/jbc.M110197200 (Pubitemid 34968313)
76. Zaidi S. I. A., Richardson S. L., Capellari S., Song L., Smith M. A., Ghetti B., Sy M.-S., Gambetti P., Petersen R. B., Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding. Journal of Alzheimer's Disease 2005 7 2 159 171 2-s2.0-17844375090 (Pubitemid 40592190)
77. Zanusso G., Petersen R. B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P., Singh N., Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. The Journal of Biological Chemistry 1999 274 33 23396 23404 2-s2.0-0033551776 10.1074/jbc.274.33.23396 (Pubitemid 29388094)
78. Wegner C., Römer A., Schmalzbauer R., Lorenz H., Windl O., Kretzschmar H. A., Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells. Journal of General Virology 2002 83 5 1237 1245 2-s2.0-0036257318 (Pubitemid 34477297)
79. Krammer C., Suhre M. H., Kremmer E., Diemer C., Hess S., Schätzl H. M., Scheibel T., Vorberg I., Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells. FASEB Journal 2008 22 3 762 773 2-s2.0-40449095371 10.1096/fj.07-8733com (Pubitemid 351348129)
80. Kristiansen M., Messenger M. J., Klöhn P.-C., Brandner S., Wadsworth J. D. F., Collinge J., Tabrizi S. J., Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. The Journal of Biological Chemistry 2005 280 46 38851 38861 2-s2.0-33644677579 10.1074/jbc.M506600200 (Pubitemid 43853788)
81. Orsi A., Fioriti L., Chiesa R., Sitia R., Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. The Journal of Biological Chemistry 2006 281 41 30431 30438 2-s2.0-33750087269 10.1074/jbc.M605320200 (Pubitemid 44582099)
82. Cohen E., Taraboulos A., Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO Journal 2003 22 3 404 417 2-s2.0-0037415754 10.1093/emboj/cdg045 (Pubitemid 36193586)
83. Gilch S., Winklhofer K. F., Groschup M. H., Nunziante M., Lucassen R., Spielhaupter C., Muranyi W., Riesner D., Tatzelt J., Schätzl H. M., Intracellular re-routing of prion protein prevents propagation of PrPsc and delays onset of prion disease. EMBO Journal 2001 20 15 3957 3966 2-s2.0-17844392850 10.1093/emboj/20.15.3957 (Pubitemid 32751812)
84. Nunziante M., Kehler C., Maas E., Kassack M. U., Groschup M., Schätzl H. M., Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication. Journal of Cell Science 2005 118 21 4959 4973 2-s2.0-27944434883 10.1242/jcs.02609 (Pubitemid 41672428)
85. Ghaemmaghami S., Watts J. C., Nguyen H.-O., Hayashi S., Dearmond S. J., Prusiner S. B., Conformational transformation and selection of synthetic prion strains. Journal of Molecular Biology 2011 413 3 527 542 2-s2.0-80054685349 10.1016/j.jmb.2011.07.021
86. Mahal S. P., Baker C. A., Demczyk C. A., Smith E. W., Julius C., Weissmann C., Prion strain discrimination in cell culture: the cell panel assay. Proceedings of the National Academy of Sciences of the United States of America 2007 104 52 20908 20913 2-s2.0-38049170555 10.1073/pnas.0710054104
87. Speare J. O., Offerdahl D. K., Hasenkrug A., Carmody A. B., Baron G. S., GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells. EMBO Journal 2010 29 4 782 794 2-s2.0-77149123027 10.1038/emboj.2009.392
88. Perutz M., Polar zippers: their role in human disease. Protein Science 1994 3 10 1629 1637 2-s2.0-0027988041 (Pubitemid 24356586)
89. Perutz M. F., Finch J. T., Berriman J., Lesk A., Amyloid fibers are water-filled nanotubes. Proceedings of the National Academy of Sciences of the United States of America 2002 99 8 5591 5595 2-s2.0-0037117519 10.1073/pnas.042681399 (Pubitemid 34411593)
90. Sunde M., Serpell L. C., Bartlam M., Fraser P. E., Pepys M. B., Blake C. C. F., Common core structure of amyloid fibrils by synchrotron X-ray diffraction. Journal of Molecular Biology 1997 273 3 729 739 2-s2.0-0031592945 10.1006/jmbi.1997.1348 (Pubitemid 27488813)
91. Goedert M., Clavaguera F., Tolnay M., The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends in Neurosciences 2010 33 7 317 325 2-s2.0-77954385676 10.1016/j.tins.2010.04.003
92. Rubinsztein D. C., Lessons from animal models of Huntington's disease. Trends in Genetics 2002 18 4 202 209 2-s2.0-0036533795 10.1016/S0168-9525(01) 02625-7 (Pubitemid 34273741)
93. Lunkes A., Lindenberg K. S., Ben-Haem L., Weber C., Devys D., Landwehrmeyer G. B., Mandel J.-L., Trottier Y., Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Molecular Cell 2002 10 2 259 269 2-s2.0-0036671821 10.1016/S1097-2765(02)00602-0 (Pubitemid 35007341)
94. Sontag E. M., Lotz G. P., Agrawal N., Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. The Journal of Neuroscience 2012 32 32 11109 11119
95. Schulte J., Littleton J. T., The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Current Trends in Neurology 2011 5 65 78
96. Roscic A., Baldo B., Crochemore C., Marcellin D., Paganetti P., Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. Journal of Neurochemistry 2011 119 2 398 407 2-s2.0-80053563760 10.1111/j.1471-4159.2011.07435.x
97. Guzhova I. V., Lazarev V. F., Kaznacheeva A. V., Ippolitova M. V., Muronetz V. I., Kinev A. V., Margulis B. A., Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease. Human Molecular Genetics 2011 20 20 3953 3963 2-s2.0-80053144772 10.1093/hmg/ddr314
98. Alba Sorolla M., Nierga C., José Rodríguez-Colman M., Reverter-Branchat G., Arenas A., Tamarit J., Ros J., Cabiscol E., Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation. Archives of Biochemistry and Biophysics 2011 510 1 27 34 2-s2.0-79955891292 10.1016/j.abb.2011.04.002
99. Herrera F., Tenreiro S., Miller-Fleming L., Outeiro T. F., Visualization of cell-to-cell transmission of mutant huntingtin oligomers. PLOS Currents 2011 3 RRN1210 10.1371/currents.RRN1210
100. Bocharova N., Chave-Cox R., Sokolov S., Knorre D., Severin F., Protein aggregation and neurodegeneration: clues from a yeast model of Huntington's disease. Biochemistry 2009 74 2 231 234 2-s2.0-61349125667 10.1134/ S0006297909020163
101. Ravikumar B., Duden R., Rubinsztein D. C., Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Human Molecular Genetics 2002 11 9 1107 1117 2-s2.0-0036566266 (Pubitemid 34521091)
102. Ravikumar B., Imarisio S., Sarkar S., O'Kane C. J., Rubinsztein D. C., Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. Journal of Cell Science 2008 121 10 1649 1660 2-s2.0-46249127490 10.1242/jcs.025726 (Pubitemid 351911822)
103. Gong B., Lim M. C. Y., Wanderer J., Wyttenbach A., Morton A. J., Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death. Brain Research Bulletin 2008 75 1 146 157 2-s2.0-37349007785 10.1016/j.brainresbull.2007.08.005 (Pubitemid 350297653)
104. Sokolov S., Pozniakovsky A., Bocharova N., Knorre D., Severin F., Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers. Biochimica et Biophysica Acta 2006 1757 5-6 660 666 2-s2.0-33745586752 10.1016/j.bbabio.2006.05.004 (Pubitemid 43993870)
105. Colby D. W., Cassady J. P., Lin G. C., Ingram V. M., Wittrup K. D., Stochastic kinetics of intracellular huntingtin aggregate formation. Nature Chemical Biology 2006 2 6 319 323 2-s2.0-33646884427 10.1038/nchembio792 (Pubitemid 43787213)
106. Wang H., Lim P. J., Yin C., Rieckher M., Vogel B. E., Monteiro M. J., Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Human Molecular Genetics 2006 15 6 1025 1041 2-s2.0-33644771265 10.1093/hmg/ddl017 (Pubitemid 43338242)
107. Mukai H., Isagawa T., Goyama E., Tanaka S., Bence N. F., Tamura A., Ono Y., Kopito R. R., Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 31 10887 10892 2-s2.0-23344440853 10.1073/pnas.0409283102 (Pubitemid 41105962)
108. Sugars K. L., Brown R., Cook L. J., Swartz J., Rubinsztein D. C., Decreased cAMP response element-mediated transcription. An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. The Journal of Biological Chemistry 2004 279 6 4988 4999 2-s2.0-1042289730 10.1074/jbc.M310226200 (Pubitemid 38199095)
109. Sittler A., Lurz R., Lueder G., Priller J., Hayer-Hartl M. K., Hartl F. U., Lehrach H., Wanker E. E., Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Human Molecular Genetics 2001 10 12 1307 1315 2-s2.0-0035363805 (Pubitemid 32600484)
110. Krobitsch S., Lindquist S., Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1589 1594 2-s2.0-0034652127 10.1073/pnas.97.4.1589 (Pubitemid 30118486)
111. Cooper J. K., Schilling G., Peters M. F., Herring W. J., Sharp A. H., Kaminsky Z., Masone J., Khan F. A., Delanoy M., Borchelt D. R., Dawson V. L., Dawson T. M., Ross C. A., Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Human Molecular Genetics 1998 7 5 783 790 2-s2.0-7144253143 10.1093/hmg/7.5.783 (Pubitemid 28221240)
112. Kidd M., Paired helical filaments in electron microscopy of Alzheimer's Disease. Nature 1963 197 4863 192 193 2-s2.0-37049048544 10.1038/197192b0
113. Berriman J., Serpell L. C., Oberg K. A., Fink A. L., Goedert M., Crowther R. A., Tau filaments from human brain and from in vitro assembly of recombinant protein show cross- β structure. Proceedings of the National Academy of Sciences of the United States of America 2003 100 15 9034 9038 2-s2.0-0042307302 10.1073/pnas.1530287100 (Pubitemid 36899218)
114. Alonso A. D. C., Grundke-Iqbal I., Barra H. S., Iqbal K., Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proceedings of the National Academy of Sciences of the United States of America 1997 94 1 298 303 2-s2.0-0031012497
115. Gong C.-X., Liu F., Grundke-Iqbal I., Iqbal K., Post-translational modifications of tau protein in Alzheimer's disease. Journal of Neural Transmission 2005 112 6 813 838 2-s2.0-18544390506 10.1007/s00702-004-0221-0 (Pubitemid 40655573)
116. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J. Q., Lee V. M.-Y., Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Molecular Biology of the Cell 2000 11 12 4093 4104 2-s2.0-0033638377
117. Khlistunova I., Biernat J., Wang Y., Pickhardt M., Von Bergen M., Gazova Z., Mandelkow E., Mandelkow E.-M., Inducible expression of tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. The Journal of Biological Chemistry 2006 281 2 1205 1214 2-s2.0-33644851265 10.1074/jbc.M507753200
118. Frost B., Jacks R. L., Diamond M. I., Propagation of Tau misfolding from the outside to the inside of a cell. The Journal of Biological Chemistry 2009 284 19 12845 12852 2-s2.0-67649273927 10.1074/jbc.M808759200
119. Kfoury N., Holmes B. B., Jiang H., Holtzman D. M., Diamond M. I., Trans-cellular propagation of Tau aggregation by fibrillar species. The Journal of Biological Chemistry 2012 287 23 19440 19451
120. Nonaka T., Watanabe S. T., Iwatsubo T., Hasegawa M., Seeded aggregation and toxicity of α -synuclein and tau: cellular models of neurodegenerative diseases. The Journal of Biological Chemistry 2010 285 45 34885 34898 2-s2.0-78049376559 10.1074/jbc.M110.148460
121. Guo J. L., Lee V. M., Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Letters 2013 587 6 717 723
122. Wu J. W., Herman M., Liu L., Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. The Journal of Biological Chemistry 2013 288 3 1856 1870
123. Guo J. L., Lee V. M.-Y., Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. The Journal of Biological Chemistry 2011 286 17 15317 15331 2-s2.0-79955441814 10.1074/jbc.M110.209296
124. Lashuel H. A., Overk C. R., Oueslati A., Masliah E., The many faces of
125. Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K., alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003 302 5646 841 2-s2.0-0242300619 10.1126/science.1090278 (Pubitemid 37339619)
126. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the α -synuclein gene identified in families with Parkinson's disease. Science 1997 276 5321 2045 2047 2-s2.0-0030744876 10.1126/science.276.5321.2045 (Pubitemid 27443610)
127. Beyer K., Ariza A., Alpha-synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Molecular Neurobiology 2013 47 2 509 524
128. Fauvet B., Mbefo M. K., Fares M. B., Desobry C., Michael S., Ardah M. T., Tsika E., Coune P., Prudent M., Lion N., Eliezer D., Moore D. J., Schneider B., Aebischer P., El-Agnaf O. M., Masliah E., Lashuel H. A., α -Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. The Journal of Biological Chemistry 2012 287 19 15345 15364
129. Xu J., Kao S.-Y., Lee F. J. S., Song W., Jin L.-W., Yankner B. A., Dopamine-dependent neurotoxicity of α -synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nature Medicine 2002 8 6 600 606 2-s2.0-0036278335 10.1038/nm0602-600 (Pubitemid 34633438)
130. Mazzulli J. R., Mishizen A. J., Giasson B. I., Lynch D. R., Thomas S. A., Nakashima A., Nagatsu T., Ota A., Ischiropoulos H., Cytosolic catechols inhibit α -synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. The Journal of Neuroscience 2006 26 39 10068 10078 2-s2.0-33749170166 10.1523/JNEUROSCI.0896-06.2006 (Pubitemid 44477168)
131. Yamakawa K., Izumi Y., Takeuchi H., Yamamoto N., Kume T., Akaike A., Takahashi R., Shimohama S., Sawada H., Dopamine facilitates α -synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochemical and Biophysical Research Communications 2010 391 1 129 134 2-s2.0-72949105341 10.1016/j.bbrc.2009.11.015
132. Bartels T., Choi J. G., Selkoe D. J., α -Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 2011 477 7362 107 110 2-s2.0-80052398365 10.1038/nature10324
133. Kahle P. J., Neumann M., Ozmen L., Haass C., Physiology and pathophysiology of α -synuclein cell culture and transgenic animal models based on a Parkinson's disease-associated protein. Annals of the New York Academy of Sciences 2000 920 33 41 2-s2.0-0034527763 (Pubitemid 32056549)
134. Bodner R. A., Outeiro T. F., Altmann S., Maxwell M. M., Cho S. H., Hyman B. T., McLean P. J., Young A. B., Housman D. E., Kazantsev A. G., Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proceedings of the National Academy of Sciences of the United States of America 2006 103 11 4246 4251 2-s2.0-33645235438 10.1073/pnas.0511256103
135. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J. M., Farer M., Wolozin B., The A53T α -synuclein mutation increases iron-dependent aggregation and toxicity. The Journal of Neuroscience 2000 20 16 6048 6054 2-s2.0-0034663039 (Pubitemid 30658398)
136. Follett J., Darlow B., Wong M. B., Goodwin J., Pountney D. L., Potassium depolarization and raised calcium induces alpha-synuclein aggregates. Neurotoxicity Research 2013 23 4 378 392
137. Gerard M., Deleersnijder A., Daniëls V., Schreurs S., Munck S., Reumers V., Pottel H., Engelborghs Y., Van Den Haute C., Taymans J.-M., Debyser Z., Baekelandt V., Inhibition of FK506 binding proteins reduces α -synuclein aggregation and Parkinson's disease-like pathology. The Journal of Neuroscience 2010 30 7 2454 2463 2-s2.0-77249126934 10.1523/JNEUROSCI.5983-09. 2010
138. Nath S., Goodwin J., Engelborghs Y., Pountney D. L., Raised calcium promotes α -synuclein aggregate formation. Molecular and Cellular Neuroscience 2011 46 2 516 526 2-s2.0-78751701091 10.1016/j.mcn.2010.12.004
139. Goodwin J., Nath S., Engelborghs Y., Pountney D. L., Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation. Neurochemistry International 2013 62 5 703 711 10.1016/j.neuint.2012.11.004
140. Kondo K., Obitsu S., Teshima R., α -Synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells. Biological and Pharmaceutical Bulletin 2011 34 7 1078 1083 2-s2.0-79960334171 10.1248/bpb.34.1078
141. Lee H.-J., Lee S.-J., Characterization of cytoplasmic α -synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. The Journal of Biological Chemistry 2002 277 50 48976 48983 2-s2.0-0037073747 10.1074/jbc.M208192200 (Pubitemid 35470869)
142. Bae E. J., Lee H. J., Rockenstein E., Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission. The Journal of Neuroscience 2012 32 39 13454 13469
143. Danzer K. M., Haasen D., Karow A. R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., Kostka M., Different species of α -synuclein oligomers induce calcium influx and seeding. The Journal of Neuroscience 2007 27 34 9220 9232 2-s2.0-34548172773 10.1523/JNEUROSCI.2617-07.2007 (Pubitemid 47312071)
144. Danzer K. M., Krebs S. K., Wolff M., Birk G., Hengerer B., Seeding induced by α -synuclein oligomers provides evidence for spreading of α -synuclein pathology. Journal of Neurochemistry 2009 111 1 192 203 2-s2.0-70349223775 10.1111/j.1471-4159.2009.06324.x
145. Luk K. C., Song C., O'Brien P., Stieber A., Branch J. R., Brunden K. R., Trojanowski J. Q., Lee V. M.-Y., Exogenous α -synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 47 20051 20056 2-s2.0-72149119358 10.1073/pnas.0908005106
146. Volpicelli-Daley L. A., Luk K. C., Patel T. P., Tanik S. A., Riddle D. M., Stieber A., Meaney D. F., Trojanowski J. Q., Lee V. M.-Y., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011 72 1 57 71 2-s2.0-80053613574 10.1016/j.neuron.2011.08.033
147. Desplats P., Lee H.-J., Bae E.-J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.-J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α -synuclein. Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13010 13015 2-s2.0-69149089854 10.1073/pnas.0903691106
148. Lee H.-J., Suk J.-E., Patrick C., Bae E.-J., Cho J.-H., Rho S., Hwang D., Masliah E., Lee S.-J., Direct transfer of α -synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. The Journal of Biological Chemistry 2010 285 12 9262 9272 2-s2.0-77950571596 10.1074/jbc.M109.081125
149. Jang A., Lee H.-J., Suk J.-E., Jung J.-W., Kim K.-P., Lee S.-J., Non-classical exocytosis of α -synuclein is sensitive to folding states and promoted under stress conditions. Journal of Neurochemistry 2010 113 5 1263 1274 2-s2.0-77951885732 10.1111/j.1471-4159.2010.06695.x
150. Lee H.-J., Patel S., Lee S.-J., Intravesicular localization and exocytosis of α -synuclein and its aggregates. The Journal of Neuroscience 2005 25 25 6016 6024 2-s2.0-21344456506 10.1523/JNEUROSCI.0692-05.2005 (Pubitemid 40911433)
151. Emmanouilidou E., Melachroinou K., Roumeliotis T., Garbis S. D., Ntzouni M., Margaritis L. H., Stefanis L., Vekrellis K., Cell-produced α -synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. The Journal of Neuroscience 2010 30 20 6838 6851 2-s2.0-77952648551 10.1523/JNEUROSCI.5699-09.2010
152. Alvarez-Erviti L., Seow Y., Schapira A. H., Gardiner C., Sargent I. L., Wood M. J. A., Cooper J. M., Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiology of Disease 2011 42 3 360 367 2-s2.0-79954631518 10.1016/j.nbd.2011.01.029
153. Cleveland D. W., Rothstein J. D., From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience 2001 2 11 806 819 2-s2.0-0035516124 10.1038/35097565 (Pubitemid 33674062)
154. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.-X., Hung W.-Y., Kato T., Asayama K., Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. Journal of Neuropathology and Experimental Neurology 1996 55 4 481 490 2-s2.0-0029927679 (Pubitemid 26112102)
155. Prudencio M., Durazo A., Whitelegge J. P., Borchelt D. R., Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. Journal of Neurochemistry 2009 108 4 1009 1018 2-s2.0-58549087977 10.1111/j.1471-4159.2008.05839.x
156. Grad L. I., Guest W. C., Yanai A., Pokrishevsky E., O'Neill M. A., Gibbs E., Semenchenko V., Yousefi M., Wishart D. S., Plotkin S. S., Cashman N. R., Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proceedings of the National Academy of Sciences of the United States of America 2011 108 39 16398 16403 2-s2.0-80053652133 10.1073/pnas.1102645108
157. Roberts B. L., Patel K., Brown H. H., Borchelt D. R., Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures. PLoS One 2012 7 10 e47838
158. Roberts K., Zeineddine R., Corcoran L., Li W., Campbell I. L., Yerbury J. J., Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia 2013 61 3 409 419
159. Mondola P., Annella T., Serù R., Santangelo F., Iossa S., Gioielli A., Santillo M., Secretion and increase of intracellular CuZn superoxide dismutase content in human neuroblastoma SK-N-BE cells subjected to oxidative stress. Brain Research Bulletin 1998 45 5 517 520 2-s2.0-0032521619 10.1016/S0361-9230(97)00438-3 (Pubitemid 28188543)
160. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., Julien J.-P., Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature Neuroscience 2006 9 1 108 118 2-s2.0-29444443348 10.1038/nn1603 (Pubitemid 43011916)
161. Gomes C., Keller S., Altevogt P., Costa J., Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neuroscience Letters 2007 428 1 43 46 2-s2.0-35448956015 10.1016/j.neulet.2007.09.024 (Pubitemid 47633803)
162. Bousset L., Pieri L., Ruiz-Arlandis G., Structural and functional characterization of two alpha-synuclein strains. Nature Communications 2013 4, article 2575 10.1038/ncomms3575